0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Does Hepatitis C Virus Infection Increase the Risk of HIV Disease Progression?

Stephen J. Rossi, PharmD; Paul A. Volberding, MD; Teresa L. Wright, MD
JAMA. 2002;288(2):241-243. doi:10.1001/jama.288.2.241.
Text Size: A A A
Published online

Extract

Liver disease is an increasingly common cause of death in patients with human immunodeficiency virus (HIV) infection.1 Acquisition of hepatitis C virus (HCV) requires blood contact through contaminated needles or by transfusion; sexual transmission of HCV is uncommon.2,3 HIV accelerates the progression of HCV-related liver disease4; thus, exploring HCV treatment in coinfected patients with HCV/HIV is a priority. To date, experience with combination therapies using interferon plus ribavirin in coinfected patients has been limited, and there are emerging concerns about interactions between those drugs and HIV therapies, particularly the interaction between ribavirin and zidovudine and between ribavirin and didanosine.5 Recent data reveal a more rapid progression to cirrhosis in individuals with HCV/HIV coinfection who have not received protease inhibitor therapy, who have consumed excess alcohol, and who have a low CD4 cell count.6 These observations suggest that effective HIV therapy may decrease the progression to advanced HCV-related liver disease.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 19

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();